HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
26 sources retrieved · Most recent: April 2026 · Index updated 15 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
BACH1
BTB domain and CNC homolog 1
Chromosome 21 · 21q21.3
NCBI Gene: 571Ensembl: ENSG00000156273.17HGNC: HGNC:935UniProt: O14867
191PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
DNA RepairTranscription Factor
RESEARCH IMPACT
Trending
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
nucleuscytosolDNA-binding transcription repressor activity, RNA polymerase II-specificprotein bindingIncreased total eosinophil countintestinal infectious diseasepancreatic carcinomamalignant renal pelvis neoplasm
✦AI Summary

BACH1 (BTB domain and CNC homolog 1) is a redox-sensitive transcription factor that functions as both a repressor and activator depending on cellular context. It binds to NF-E2 DNA binding sites and acts as a heme-binding protein whose stability is inversely regulated by oxidative stress 1. Under reduced ROS conditions, BACH1 stabilization promotes metabolic reprogramming toward glycolysis and mitochondrial dysfunction, which facilitates cancer progression 23. In cancer biology, BACH1 demonstrates pleiotropic pro-tumoral functions. It stimulates angiogenesis gene expression in a HIF1α-independent manner 4 and promotes ferroptosis resistance by competing with NRF2 to suppress ferroptosis-regulatory pathways 5. In glioblastoma, BACH1 activity increases in infiltrating tumor cells, and combined BACH1 and AP-1 inhibition synergistically suppresses progression 6. Beyond cancer, BACH1 functions as a mechanosensor of hemodynamic stress in endothelial cells. It forms a transcriptional complex with YAP to upregulate adhesion molecules and proinflammatory cytokines, promoting atherosclerotic lesion formation 7. In hepatic metabolism, BACH1 suppresses insulin signaling by facilitating PTP1B-mediated inhibition of the insulin receptor, contributing to insulin resistance and metabolic syndrome 8. BACH1 thus emerges as a multifaceted therapeutic target across multiple disease contexts.

Sources cited
1
BACH1 stabilization by antioxidants activates glycolysis and promotes lung cancer metastasis
PMID: 31257027
2
BACH1 deletion in endothelial cells reduces atherosclerosis through suppression of the BACH1-YAP inflammatory axis
PMID: 35196865
3
BACH1 is a redox- and oxygen-sensitive transcription factor controlling angiogenesis gene expression independently of HIF1α
PMID: 37651203
4
BACH1 and NRF2 competitively regulate ferroptosis through control of iron metabolism, GSH-GPX4, and FSP1-CoQ pathways
PMID: 35107212
5
Hepatic BACH1 suppresses insulin signaling by promoting PTP1B interaction with insulin receptor β
PMID: 38129407
6
BACH1 activity increases in infiltrating glioblastoma cells; combined AP-1/BACH1 inhibition improves therapeutic efficacy
PMID: 39576855
7
BACH1 negatively regulates electron transport chain genes and sensitizes cells to mitochondrial inhibitors when depleted
PMID: 30842661
8
NRF2 stabilizes BACH1 through HO1-mediated heme degradation and suppression of Fbxo22-dependent ubiquitination
PMID: 31257023
Disease Associationsⓘ20
Increased total eosinophil countOpen Targets
0.30Weak
intestinal infectious diseaseOpen Targets
0.30Weak
pancreatic carcinomaOpen Targets
0.27Weak
malignant renal pelvis neoplasmOpen Targets
0.25Weak
heart failureOpen Targets
0.24Weak
coronary artery diseaseOpen Targets
0.23Weak
ProptosisOpen Targets
0.21Weak
hemorrhoidOpen Targets
0.17Weak
neoplasmOpen Targets
0.12Weak
Cerebellar vermis hypoplasiaOpen Targets
0.11Weak
cancerOpen Targets
0.11Weak
breast cancerOpen Targets
0.10Weak
triple-negative breast cancerOpen Targets
0.10Suggestive
hepatocellular carcinomaOpen Targets
0.10Suggestive
esophageal squamous cell carcinomaOpen Targets
0.09Suggestive
lung cancerOpen Targets
0.09Suggestive
lung adenocarcinomaOpen Targets
0.08Suggestive
glioblastoma multiformeOpen Targets
0.08Suggestive
rheumatoid arthritisOpen Targets
0.08Suggestive
acute myeloid leukemiaOpen Targets
0.08Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
ZNF668Shared pathway100%ERCC6LShared pathway100%FBXL17Protein interaction98%MAFGProtein interaction98%MAFFProtein interaction90%HMMRProtein interaction88%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
48%
Brain
29%
Heart
27%
Liver
26%
Ovary
17%
Gene Interaction Network
Click a node to explore
BACH1ZNF668ERCC6LFBXL17MAFGMAFFHMMR
PROTEIN STRUCTURE
Preparing viewer…
PDB9GRA · 1.47 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.84LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.63 [0.47–0.84]
RankingsWhere BACH1 stands among ~20K protein-coding genes
  • #2,240of 20,598
    Most Researched191 · top quartile
  • #7,164of 17,882
    Most Constrained (LOEUF)0.84
Genes detectedBACH1
Sources retrieved26 papers
Response time—
📄 Sources
26▼
1
BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis.
PMID: 31257027
Cell · 2019
1.00
2
Deletion of BACH1 Attenuates Atherosclerosis by Reducing Endothelial Inflammation.
PMID: 35196865
Circ Res · 2022
0.90
3
Antioxidants stimulate BACH1-dependent tumor angiogenesis.
PMID: 37651203
J Clin Invest · 2023
0.80
4
Ferroptosis: regulation by competition between NRF2 and BACH1 and propagation of the death signal.
PMID: 35107212
FEBS J · 2023
0.70
5
UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis.
PMID: 36419136
J Exp Clin Cancer Res · 2022
0.64